Thryv Holdings, Inc. (THRY)
After hours:
| Previous Close | 21.45 |
| Open | 21.43 |
| Bid | 20.97 x 100 |
| Ask | 21.15 x 100 |
| Day's Range | 21.00 - 21.70 |
| 52 Week Range | 15.99 - 26.42 |
| Volume | |
| Avg. Volume | 174,387 |
| Market Cap | 768.57M |
| Beta (5Y Monthly) | 0.97 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -7.50 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 29.50 |
CNW GroupThryv Therapeutics to Present Preclinical Data of SGK1 Inhibition in Models of Drug-Induced QT Prolongation at the 2024 Heart Rhythm Society Meeting
Thryv Therapeutics Inc., a biotechnology company pioneering precision treatment to treat indications including Congenital Long QT Syndrome, atrial fibrillation, and heart failure, today announced a poster presentation of SGK1 inhibition in models of Drug-Induced QT prolongation at the 2024 Heart Rhythm Society meeting in Boston, MA. This presentation will take place on Friday, May 17th, from 10:30 a.m. to 12:30 p.m. ET. The meeting will commence with a presentation by Thryv co-founder and Princi
Insider MonkeyThryv Holdings, Inc. (NASDAQ:THRY) Q1 2024 Earnings Call Transcript
Thryv Holdings, Inc. (NASDAQ:THRY) Q1 2024 Earnings Call Transcript May 4, 2024 Thryv Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name is Dee and I will be your conference operator today. At this time, […]
Business WireThryv to Participate in Upcoming Investor Conferences
DALLAS, May 06, 2024--Thryv Holdings, Inc. (NASDAQ:THRY) ("Thryv" or the "Company"), the provider of Thryv®, the leading small business software platform, announced today members of its management team will host 1:1 meetings at the following upcoming investor conferences:
